1. Introduction {#sec0005}
===============

The Zika virus spreads among humans primarily through an infected mosquito bite, which has been increasing at an alarming incidence rate worldwide over the past few years ([@bib0020]). It belongs to the family of flaviviruses which includes more than fifty viruses, such as dengue, yellow fever, and the West Nile virus.

This virus was first identified in the Zika forests of Uganda and East Africa during the investigations on the ecology of the yellow fever ([@bib0010]). The first isolation was made in April of 1947 from the serum of pyrexia rhesus monkey caged. The second isolation was made in 1947 in the same forest ([@bib0020]). Just a year later, in 1948, the virus was recovered from mosquito Aedes Africanus from the Zika forest. The first human case of Zika fever was reported in Uganda in 1952. The first outbreak of Zika fever was reported in 2007 on the Pacific island of Yap, this outbreak caused 108 symptomatic cases. Another epidemic outbreak occurred in French Polynesia between 2012 and 2014. During this time, it was estimated that about 28,000 people were reported to have Zika like symptoms ([@bib0010]).

Recently a large and sustained epidemic in Brazil was confirmed in April 2015. Thousands of symptomatic cases have been reported. Brazilian authorities have indeed confirmed that over 500 cases with flu-like symptoms were due to the Zika virus. Thus, owing to its recent spread outside Africa and Pacific Asia, the Zika virus can be considered an emerging pathogen. The Pan American Health Organization (PAHO), reported more than 100,000 cases of Zika virus by the end of 2016. Only 9 deaths were reported in that period ([@bib0145]).

Brazil was by far the country that was most affected by this epidemic, reporting the most cases of people infected with the Zika virus worldwide. In 2016, the state of Rio de Janeiro alone reported over 71,000 probable Zika virus infections, however, this number dropped to only 2210 cases in 2017.

Sexual transmission of the Zika virus has also been reported from both males and females to their partners ([@bib0015], [@bib0080], [@bib0160]). Zika virus can be sexually transmitted from a person who is infected by the virus, even while they are not symptomatic. Furthermore, it has been suggested that Zika virus can be transmitted from a pregnant woman to her fetus during pregnancy. Zika virus can be transferred horizontally as well as vertically. During the Zika epidemic, Brazilian health officials reported an increase in the number of cases of microcephaly disease, a condition in which a baby\'s head is smaller than normal in Zika affected areas.

The main symptoms of Zika fever include a fever, the Maculopapular rash often spreading from the face to the body, joint and muscle pain, vomiting, or bilateral non-purulent conjunctivitis ([@bib0050]). The first well-documented case of Zika fever was reported in 1964 and started with a mild headache with later development of a maculopapular rash, fever, and back pain ([@bib0085]). The symptoms of Zika fever are thus quite similar to those of Dengue fever and there is a strong possibility of misdiagnosis in regions where Dengue virus is common.

The incubation period for the Zika virus is between 3 and 14 days ([@bib0025]). Disease-related symptoms are developed within one week of infection for 50% of the infected individuals and within 2 weeks among 99% ([@bib0025]) of the infected individuals. The vast majority of infections are not contagious from person to person; however, it may be passed person to person during sex. The virus infection is usually diagnosed by a blood test. The disease symptoms are usually mild and short lasting (17 days), and infection may go unrecognized or be misdiagnosed as Dengue fever ([@bib0050]).

Unfortunately, there is no vaccine, antiviral drug, or other modality available to prevent or treat the Zika virus infection. Zika fever is a preventable but not a curable disease. Thus, the only means of controlling the Zika virus is to control the mosquitoes that spread the disease and protection during sex.

In the past several years, a number of deterministic models for the transmission dynamics of the Dengue virus have been studied and analyzed ([@bib0030], [@bib0035], [@bib0045], [@bib0055], [@bib0065], [@bib0070], [@bib0105], [@bib0185]). After the Zika outbreak, models for Zika transmission have been developed ([@bib0005], [@bib0135], [@bib0190]) and analyzed. In these models, the authors included the effect of sexual transmission of the disease.

In this work, we formulate and study a deterministic model for Zika virus transmission including vertical and horizontal transmission of the disease. Although Esteva ([@bib0040]) discussed vertical disease transmission it was among vectors in a Dengue transmission.

Our deterministic model for Zika virus transmission includes horizontal and vertical transmission in both humans and vectors. As stated previously, it has been suggested that Zika virus can spread to newborns from their mothers, and we therefore feel that an accurate model must include the vertical transmission. Our work is an extension of our previous model ([@bib0100]) by including a population group that is using controlling measures. In the previous work, we considered death due to the infection and the total human and vector populations were functions of time. The previous model did not possess global stability for both disease-free and endemic equilibriums. We showed a backward bifurcation phenomenon. The current model has constant population size. Since death cases reported from Zika fever were negligible, we take disease-induced mortality to be zero. There is no backward bifurcation and the steady states results are global. Since the only way to control the disease is to isolate patients who have been infected with the Zika virus, we included a new population compartment consisting of hospitalized individuals. We have calculated the basic reproductive number associated with our model that guarantees the elimination of the disease. Finally, using optimal control techniques, we also propose and analyze the control strategies for decrease infected individuals while minimizing the costs and resources simultaneously.

The rest of this paper is organized as follows, the proposed model is presented in Section [2](#sec0010){ref-type="sec"}. Basic properties and a detailed steady-state analysis of the model are presented in Section [3](#sec0015){ref-type="sec"}. In Section [4](#sec0040){ref-type="sec"}, we perform a sensitivity and uncertainty analysis of the model parameters and reproductive number associated with our model. Section [5](#sec0045){ref-type="sec"} uses ideas from optimal control theory to propose various controlling strategies to overcome Zika are proposed. Finally, Section [6](#sec0055){ref-type="sec"} presents our conclusions and contains a brief discussion of our results.

2. Model formulation {#sec0010}
====================

We consider two types of populations in this model one for the humans and for the mosquitoes. The total human and mosquitoes populations at time *t*, denoted by *N* ~*h*~ and $N_{v}$, are constant. The human population is divided into five mutually exclusive groups, susceptible humans *S* ~*h*~(*t*), exposed humans *E* ~*h*~(*t*), infected humans *I* ~*h*~(*t*), isolated or hospitalized individuals *H* ~*h*~(*t*) and recovered humans *R* ~*h*~(*t*). The total vector population is divided into three mutually exclusive classes comprising of susceptible vectors $S_{v}(t)$, exposed vectors $E_{v}(t)$ and infected vectors $I_{v}(t)$. The model assumes that the susceptible human population *S* ~*h*~(*t*) has a recruitment rate *μ* ~*h*~ *N* ~*h*~, where *N* ~*h*~ is total human population and *μ* ~*h*~ is the natural birth rate of humans. We assume that the birth rate of human population is same as the natural death rate. Susceptible individuals get infected with Zika fever virus (due to contact with infected vectors) at a rate *λ* ~*h*~ and thus enter the exposed class *E* ~*h*~. In order to consider vertical transmission in our model, we make the assumption (see, e.g., [@bib0120]) that a fraction of newborn individuals from parents in the *E* ~*h*~(*t*) and *I* ~*h*~(*t*) classes will be infected, and thus remain in *E* ~*h*~ class before becoming infectious. We have assumed that the hospitalized individuals do not contribute to vertical transmission. Population in each class is removed at the natural death rate *μ* ~*h*~. We assumed a lifelong immunity for humans who recovered from Zika virus. The exposed individuals who got an infection, move to infectious class at a rate *ξ*. The infected population recovers from the Zika fever at a rate *θ* ~*I*~ and some infected individuals are transferred to hospitalized class at a rate *τ*. The hospitalized population recovered at a rate of *θ* ~*H*~.

The susceptible vector population $S_{v}(t)$ has a recruitment rate $\mu_{v}N_{v}$, and $\mu_{v}$ is a natural death rate of vector population. A fraction of offsprings in the $E_{v}(t)$ and $I_{v}(t)$ classes will be infected, and thus remain in *E* ~*h*~ class before becoming infectious. Because of this vertical transmission, a fraction of susceptible individuals will enter the exposed class. Susceptible vectors are infected with Zika virus (due to effective contact with infected humans) at a rate of $\lambda_{v}$ and thus move to the exposed vector class $E_{v}$. The susceptible, exposed and infected vectors have natural death rate $\mu_{v}.$ In addition, exposed vectors develop symptoms and move to the infected vector class $I_{v}$ at a rate of $\sigma_{v}$. It is assumed that infected vectors do not recover, and die at the natural death rate of $\mu_{v}$.

As mentioned earlier there is no vaccine available for Zika fever. The only way to control this disease is to reduce the contact rate either by killing the mosquitoes or using the protective measure like mosquito repellents, nets etc. The effective contacts will be further reduced by isolating the infected humans. Isolation of individuals with disease symptoms constitutes what is probably the first infection control measure since the beginning of recorded human history ([@bib0090]). Over the decades, these control measures have been applied, with varying degrees of success, to combat the spread of some emerging and re-emerging diseases such as leprosy, plague, cholera, typhus, yellow fever, smallpox, diphtheria, tuberculosis, measles, Ebola, pandemic influenza and, more recently, severe acute respiratory syndrome ([@bib0075], [@bib0095], [@bib0125], [@bib0130]). Chavez et al. analyzed a SAIQR model in detail, to investigate the effect of isolation on influenza ([@bib0180]). They used the isolation (quarantine) I-Q model, where the infected population is isolated. We have included epidemiological factors like permanent or partial immunity after recovery as well as intervention control measures through the inclusion of a hospitalized (or isolated) class, *H* ~*h*~.$$\begin{array}{rcl}
\frac{{dS}_{h}}{dt} & = & {N_{h}\mu_{h} - p\mu_{h}E_{h} - q\mu_{h}I_{h} - \lambda_{h}S_{h} - \mu_{h}S_{h}} \\
\frac{{dE}_{h}}{dt} & = & {\lambda_{h}S_{h} + p\mu_{h}E_{h} + q\mu_{h}I_{h} - (\xi + \mu_{h})E_{h}} \\
\frac{{dI}_{h}}{dt} & = & {\xi E_{h} - (\theta_{I} + \tau + \mu_{h})I_{h}} \\
\frac{{dH}_{h}}{dt} & = & {\tau I_{h} - (\theta_{H} + \mu_{h})H_{h}} \\
\end{array}\begin{array}{rcl}
\frac{{dR}_{h}}{dt} & = & {\theta_{I}I_{h} + \theta_{H}H_{h} - \mu_{h}R_{h}} \\
\frac{{dS}_{v}}{dt} & = & {N_{v}\mu_{v} - r\mu_{v}E_{v} - s\mu_{v}I_{v} - \lambda_{v}S_{v} - \mu_{v}S_{v}} \\
\frac{{dE}_{v}}{dt} & = & {r\mu_{v}E_{v} + s\mu_{v}I_{v} + \lambda_{v}S_{v} - (\sigma_{v} + \mu_{v})E_{v}} \\
\frac{{dI}_{v}}{dt} & = & {\sigma_{v}E_{v} - \mu_{v}I_{v}.} \\
\end{array}$$

In this case both the total host population and the vector population are constant.

The forces of infection *λ* ~*h*~ and $\lambda_{v}$ are given as ([@bib0065]):$$\begin{aligned}
{\lambda_{h} = \frac{C_{hv}}{N_{h}}I_{v}\quad{and}\quad\lambda_{v} = \frac{C_{hv}}{N_{h}}(I_{h} + \eta H_{h}).} & \\
\end{aligned}$$

Here we assumed that an individual in *H* class still can transmit the disease but with lower rate. The value of modification parameter 0 ≤ *η* \< 1.

[Fig. 1](#fig0005){ref-type="fig"} presents schematic diagram of the model [(1)](#eq0005){ref-type="disp-formula"}.Fig. 1Schematic diagram of the model [(1)](#eq0005){ref-type="disp-formula"}.Fig. 1

A description of the variables and parameters of the model [(1)](#eq0005){ref-type="disp-formula"} is given in [Table 1](#tbl0005){ref-type="table"}, [Table 2](#tbl0010){ref-type="table"} respectively.Table 1Description of the variables of the model [(1)](#eq0005){ref-type="disp-formula"}.Table 1VariableDescription*N*~*h*~Total human population$N_{v}$Total vector population*S*~*h*~Population of susceptible humans*E*~*h*~Population of exposed humans*I*~*h*~Population of infected humans*H*~*h*~Population of hospitalized humans*R*~*h*~Population of recovered humans$S_{v}$Population of susceptible vectors$E_{v}$Population of exposed vectors$I_{v}$Population of infected vectorsTable 2Description of the parameters of the model [(1)](#eq0005){ref-type="disp-formula"}.Table 2ParameterDescription*μ*~*h*~Natural death rate of humans$\mu_{v}$Natural death rate of vectors*p*Fraction of new born from exposed humans*q*Fraction of new born from infected humans*r*Fraction of offsprings from exposed vectors*s*Fraction of offsprings from infected vectors*θ*~*I*~Recovery rate of infected humans*θ*~*H*~Recovery rate of hospitalized humans*ξ*Progression rate of humans from exposed to infected class*τ*Hospitalization rate of infected individuals$\sigma_{v}$Progression rate of vectors from exposed to infected class*C*~*hv*~Effective contact rate*η*Modification parameter for relative infectiousness of hospitalized humans

The model [(1)](#eq0005){ref-type="disp-formula"} will be studied on the closed set:$$\begin{aligned}
{\mathcal{B} = \{(S_{h},E_{h},I_{h},H_{h},R_{h},S_{v},E_{v},I_{v}) \in \mathbb{R}_{+}^{8}:S_{h} + E_{h} + I_{h} + H_{h} + R_{h} = N_{h};} & \\
{S_{v} + E_{v} + I_{v} = N_{v}\}.} & \\
\end{aligned}$$ $\mathcal{B}$ is positively invariant and attracting with respect to the model [(1)](#eq0005){ref-type="disp-formula"}. It can be seen that the solutions are always positive. The right sides of [(1)](#eq0005){ref-type="disp-formula"} are smooth, so that initial value problems have unique solutions that exist on maximal intervals. Since paths cannot leave $\mathcal{B}$, solutions exist for all positive time. Thus the model is mathematically and epidemiologically well posed.

3. Basic reproductive number and steady states analysis {#sec0015}
=======================================================

In this section, we will perform a detailed steady state and stability analysis of the Zika fever model presented in Section [2](#sec0010){ref-type="sec"}.

3.1. Basic reproductive number and local stability of disease free equilibrium {#sec0020}
------------------------------------------------------------------------------

The model [(1)](#eq0005){ref-type="disp-formula"} has a disease free equilibrium (DFE) given by$$\mathcal{E}_{0} = \left( {S_{h}^{*},E_{h}^{*},I_{h}^{*},H_{h}^{*},R_{h}^{*},S_{v}^{*},E_{v}^{*},I_{v}^{*}} \right) = \left( {N_{h},0,0,0,0,N_{v},0,0} \right)$$In order to investigate the local stability of the DFE $(\mathcal{E}_{0})$, the next generation operator method ([@bib0170]) will be used. Following the notation of [@bib0170], the matrix *F* (for the new infection terms) and the matrix *V* (of the transition terms) are given, respectively, by$$\begin{aligned}
F & {= \begin{pmatrix}
0 & 0 & 0 & 0 & C_{hv} \\
0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 \\
0 & {\frac{C_{hv}}{N_{h}}S_{v}^{*}} & {\frac{C_{hv}}{N_{h}}\eta S_{v}^{*}} & 0 & 0 \\
0 & 0 & 0 & 0 & 0 \\
\end{pmatrix},} \\
V & {= \begin{pmatrix}
{- p\mu_{h} + K_{1}} & {- q\mu_{h}} & 0 & 0 & 0 \\
{- \xi} & K_{2} & 0 & 0 & 0 \\
0 & {- \tau} & K_{3} & 0 & 0 \\
0 & 0 & 0 & {- r\mu_{v} + K_{4}} & {- s\mu_{v}} \\
0 & 0 & 0 & {- \sigma_{v}} & K_{5} \\
\end{pmatrix}} \\
\end{aligned}$$where *K* ~1~ = *ξ* + *μ* ~*h*~, *K* ~2~ = *θ* ~*I*~ + *τ* + *μ* ~*h*~, *K* ~3~ = *θ* ~*H*~ + *μ* ~*h*~, $K_{4} = \sigma_{v} + \mu_{v}$, and $K_{5} = \mu_{v}$.

The basic reproduction number *R* ~0~ for our model is given by$$\begin{array}{lll}
{R_{0} = \rho(FV^{- 1})} & = & \sqrt{\frac{C_{hv}^{2}N_{v}\xi\sigma_{v}(K_{3} + \eta\tau)}{N_{h}K_{3}\lbrack(K_{1} - p\mu_{h})K_{2} - q\mu_{h}\xi\rbrack\lbrack(K_{4} - r\mu_{v})K_{5} - s\mu_{v}\sigma_{v}\rbrack}} \\
 & = & {\sqrt{\frac{C_{hv}^{2}N_{v}\xi\sigma_{v}(K_{3} + \eta\tau)}{N_{h}\lbrack K_{2}\mu_{h}(1 - p) + \xi(\theta_{I} + \tau + \delta_{I} + \mu_{h}(1 - q)\rbrack\lbrack K_{5}\mu_{v}(1 - r) + \sigma_{v}(\delta_{v} + \mu_{v}(1 - s)}\rbrack}{> 0}.} \\
\end{array}$$

When *p* = *q* = 0, vertical transmission is not present in the model; the above *R* ~0~ reduces to the basic reproduction number *R* ~0~ of a SEIR model for a vector disease ([@bib0065]).

To get a better understanding of the basic reproduction number *R* ~0~ in [(2)](#eq0030){ref-type="disp-formula"}, we rewrite it using Taylor expansion about *p* and *q*:$$\begin{array}{r}
\begin{aligned}
R_{0}^{2} & {= \frac{C_{hv}^{2}N_{v}\xi\sigma_{v}}{N_{h}K_{1}K_{2}K_{3}K_{4}K_{5}}\lbrack 1 + \frac{K_{2}p\mu_{h} + q\mu_{h}\xi}{K_{1}K_{2}} + \frac{K_{5}r\mu_{v} + s\mu_{v}\sigma_{v}}{K_{4}K_{5}} + {(R)}^{2} + \cdots\rbrack,} \\
 & {= R_{c}\lbrack 1 + \frac{K_{2}p\mu_{h} + q\mu_{h}\xi}{K_{1}K_{2}} + \frac{K_{5}r\mu_{v} + s\mu_{v}\sigma_{v}}{K_{4}K_{5}} + {(R)}^{2} + \cdots\rbrack,} \\
 & {= R_{c}(1 + R + R^{2} + \cdots),} \\
\end{aligned} \\
\end{array}$$where$$R_{c} = \frac{C_{hv}^{2}N_{v}\xi\sigma_{v}(K_{3} + \eta\tau)}{N_{h}K_{1}K_{2}K_{3}K_{4}K_{5}}\quad{and}\quad R = \frac{p\mu_{h}K_{2} + q\mu_{h}K_{1}}{K_{1}K_{2}} + \frac{K_{5}r\mu_{v} + s\mu_{v}\sigma_{v}}{K_{4}K_{5}}.$$Now$$R = R_{p} + R_{q} + R_{r} + R_{s} = \frac{p\mu_{H}}{K_{1}} + \frac{q\mu_{H}\xi}{K_{1}K_{2}} + \frac{r\mu_{V}}{K_{4}} + \frac{s\mu_{V}\sigma_{v}}{K_{4}K_{5}}.$$

Note that *R* ~*c*~ is the basic reproductive number for horizontal transmission ([@bib0110]). The square root means that the two generations required for an infected vector or host to reproduce itself ([@bib0170]). *R* ~*p*~ + *R* ~*q*~ is the sum of the number of infected individuals during the mean latent period and the number of infected individuals during the mean infectious period. Similarly, *R* ~*r*~ + *R* ~*s*~ is the sum of the number of infected vector offsprings during the mean latent period and the number of infected vector offsprings during the mean infectious period. The expression *R* = *R* ~*c*~ *R* ~*p*~ + *R* ~*c*~ *R* ~*q*~ + *R* ~*c*~ *R* ~*r*~ + *R* ~*c*~ *R* ~*s*~) represents the total contribution to the infective class made by the exposed and infective individuals of first generation ([@bib0120]). The local stability of the disease free equilibrium follows directly from [@bib0170]. We have following result about local and global stability of disease free state:Lemma 3.1*The DFE* $(\mathcal{E}_{0})$ *of the model (2.1), is locally-asymptotically stable if R* ~0~ \< 1*, and unstable if R* ~0~ \> 1*.* Theorem 3.2*The DFE,* $\mathcal{E}_{0} = \left( {N_{h},0,0,0,0,N_{v},0,0} \right)$ *, of the model* [(1)](#eq0005){ref-type="disp-formula"} *is globally-asymptotically stable in* $\mathcal{B}$ *whenever R* ~0~ \< 1*.* ProofLet $x(t) = (S_{h}(t),E_{h}(t),I_{h}(t),H_{h},R_{h}(t),S_{v}(t),E_{v}(t),I_{v}(t))$ be a solution of [(1)](#eq0005){ref-type="disp-formula"} with *x* ~0~ = *x*(0).A comparison theorem will be used for the proof. The equations for the infected components of [(1)](#eq0005){ref-type="disp-formula"} can be written as (where the prime denotes the derivative with respect to time), $$\begin{aligned}
\begin{pmatrix}
E_{h}^{\prime} \\
I_{h}^{\prime} \\
H_{h}^{\prime} \\
E_{v}^{\prime} \\
I_{v}^{\prime} \\
\end{pmatrix} & {= \left( {F - V} \right)\begin{pmatrix}
E_{h} \\
I_{h} \\
H_{h} \\
E_{v} \\
I_{v} \\
\end{pmatrix} - (1 - \frac{S_{h}}{N_{h}})\begin{pmatrix}
0 & 0 & 0 & 0 & C_{hv} \\
0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 \\
\end{pmatrix}\begin{pmatrix}
E_{h} \\
I_{h} \\
H_{h} \\
E_{v} \\
I_{v} \\
\end{pmatrix}} \\
 & {- (1 - \frac{S_{v}}{N_{v}})\begin{pmatrix}
0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 \\
0 & 0 & 0 & 0 & 0 \\
0 & \frac{C_{hv}S_{v}*}{N_{h}} & \frac{\eta C_{hv}S_{v}*}{N_{h}} & 0 & 0 \\
0 & 0 & 0 & 0 & 0 \\
\end{pmatrix}\begin{pmatrix}
E_{h} \\
I_{h} \\
H_{h} \\
E_{v} \\
I_{v} \\
\end{pmatrix}} \\
 & {\leq (F - V)\begin{pmatrix}
E_{h} \\
I_{h} \\
H_{h} \\
E_{v} \\
I_{v} \\
\end{pmatrix}} \\
\end{aligned}$$Lemma 3.1 established the local asymptotic stability of the DFE when *R* ~0~ \< 1, or equivalently, *ρ*(*FV* ^−1^)\< 1, which is equivalent to all eigenvalues of *F* − *V* having negative real parts when *R* ~0~ \< 1 ([@bib0170]). Also, *F* − *V* has all off-diagonal entries non negative. Then $\left. E_{h}(t);I_{h}(t);H_{h}(t);E_{v}(t);I_{v}(t)\rightarrow 0 \right.$ as *t* → ∞ (see Corollary B.2. in \[38\]). Substituting $E_{h} = I_{h} = {H_{h} =}E_{v} = I_{v} = 0$ into the model (1) gives *S* ~*h*~ → *N* ~*h*~, *R* ~*h*~ → 0 and $\left. S_{v}\rightarrow N_{v} \right.$ as *t* → ∞. This means that the Omega limit set of *x* ~0~, *ω*(*x* ~0~), is contained in the disease-free space. But, on the other hand, it is straightforward to check that every solution with the initial condition in the disease-free space converges to $\mathcal{E}_{0}$. Hence $\mathcal{E}_{0} \in \omega(x_{0})$. This implies that, in fact, $\omega(x_{0}) = \mathcal{E}_{0}$ (because *N* ~0~ is asymptotically stable). Thus, $\left. x(t)\rightarrow\mathcal{E}_{0} \right.$ as *t* → 0, which completes the proof.  □

The epidemiological implication of the above result is that the disease can be eliminated from the population if the basic reproduction number *R* ~0~ can be brought down to a value less than unity (that is, the condition *R* ~0~ \< 1 is sufficient and necessary for disease elimination) irrespective of the size of the initial populations in each class. The stability of the DFE is demonstrated in [Fig. 2](#fig0010){ref-type="fig"} a. If *R* ~0~ \> 1 the DFE is unstable in this case and the solutions are attracted to an (apparently unique and stable) endemic equilibrium, as depicted in [Fig. 2](#fig0010){ref-type="fig"}b.Fig. 2(a and b) Time series of the model [(1)](#eq0005){ref-type="disp-formula"} converging to possible steady states.Fig. 2

3.2. Existence of endemic state {#sec0025}
-------------------------------

In this section, the existence and stability of endemic equilibrium (EE) of the model [(1)](#eq0005){ref-type="disp-formula"} will be discussed. We define endemic equilibrium to be those fixed points of the system [(1)](#eq0005){ref-type="disp-formula"} in which at least one of the infected compartments of the model are non-zero.Theorem 3.3*The Endemic State,* $\mathcal{E}_{1}$ *, of the model* [(1)](#eq0005){ref-type="disp-formula"} *exists whenever R* ~0~ \> 1*.* ProofLet $\mathcal{E}_{1} = (S_{h}^{ø},E_{h}^{ø},I_{h}^{ø},H_{h}^{ø},R_{h}^{ø},S_{v}^{ø},E_{v}^{ø},I_{v}^{ø})$ denote an arbitrary endemic equilibrium of the model [(1)](#eq0005){ref-type="disp-formula"}. Also, let $$\lambda_{h}^{ø} = \frac{C_{hv}I_{v}^{ø}}{N_{h}},\quad\lambda_{v}^{ø} = \frac{C_{hv}(I_{h}^{ø} + \eta H_{h}^{ø})}{N_{h}}$$Solving the equations of the model [(1)](#eq0005){ref-type="disp-formula"} for steady-state by setting right hand asides of the model [(1)](#eq0005){ref-type="disp-formula"} equal to zero yields$$\begin{aligned}
S_{h}^{ø} & {= \frac{N_{h}\mu_{h}m_{1}}{m_{1}(\lambda_{h}^{ø} + \mu_{h}) + p\lambda_{h}^{ø}\mu_{h}K_{2} + q\lambda_{h}^{ø}\mu_{h}\xi};} \\
E_{h}^{ø} & {= \frac{\lambda_{h}^{ø}N_{h}\mu_{h}K_{2}}{m_{1}(\lambda_{h}^{ø} + \mu_{h}) + p\lambda_{h}^{ø}\mu_{h}K_{2} + q\lambda_{h}^{ø}\mu_{h}\xi};} \\
I_{h}^{ø} & {= \frac{\xi\lambda_{h}^{ø}N_{h}\mu_{h}}{m_{1}(\lambda_{h}^{ø} + \mu_{h}) + p\lambda_{h}^{ø}\mu_{h}K_{2} + q\lambda_{h}^{ø}\mu_{h}\xi};} \\
H_{h}^{ø} & {= \frac{\tau\xi\lambda_{h}^{ø}N_{h}\mu_{h}}{K_{3}(m_{1}(\lambda_{h}^{ø} + \mu_{h}) + p\lambda_{h}^{ø}\mu_{h}K_{2} + q\lambda_{h}^{ø}\mu_{h}\xi)};} \\
R_{h}^{ø} & {= \frac{\xi\lambda_{h}^{ø}N_{h}\mu_{h}(\theta_{I} + \theta_{H}}{K_{3}\mu_{h}\left( {m_{1}(\lambda_{h}^{ø} + \mu_{h}) + p\lambda_{h}^{ø}\mu_{h}K_{2} + q\lambda_{h}^{ø}\mu_{h}\xi} \right)};} \\
S_{v}^{ø} & {= \frac{N_{v}\mu_{v}m_{2}}{m_{2}(\lambda_{v}^{ø} + \mu_{v}) + r\lambda_{v}^{ø}\mu_{v}K_{4} + q\lambda_{v}^{ø}\mu_{v}\sigma_{v}};} \\
E_{v}^{ø} & {= \frac{\lambda_{v}^{ø}N_{v}\mu_{v}K_{4}}{m_{2}(\lambda_{v}^{ø} + \mu_{v}) + r\lambda_{v}^{ø}\mu_{v}K_{4} + s\lambda_{v}^{ø}\mu_{v}\sigma_{v}};} \\
I_{v}^{ø} & {= \frac{\sigma_{v}\lambda_{v}^{ø}N_{v}\mu_{v}}{m_{2}(\lambda_{v}^{ø} + \mu_{v}) + r\lambda_{v}^{ø}\mu_{v}K_{4} + s\lambda_{v}^{ø}\mu_{v}\sigma_{v}}.} \\
\end{aligned}$$Where *m* ~1~ = *K* ~2~(*K* ~1~ − *pμ* ~*h*~) − *qμ* ~*h*~ *ξ*, $m_{2} = K_{5}(K_{4} - r\mu_{v}) - s\mu_{v}\sigma_{v}$ and all *K*′*s* are defined above. Substituting [(4)](#eq0060){ref-type="disp-formula"} in [(3)](#eq0055){ref-type="disp-formula"} and simplifying gives,$$\lambda_{h}^{ø} = \frac{C_{hv}\sigma_{v}\lambda_{v}^{ø}N_{v}\mu_{v}\mu_{h}}{N_{h}\mu_{h}\lbrack m_{2}(\lambda_{v}^{ø} + \mu_{v}) + r\lambda_{v}^{ø}\mu_{v}K_{4} + s\lambda_{v}^{ø}\mu_{v}\sigma_{v}\rbrack}$$Also,$$\lambda_{v}^{ø} = \frac{C_{hv}\lambda_{h}^{ø}\xi\mu_{h}(K_{3} + \eta\tau)}{K_{3}\lbrack m_{1}(\lambda_{h}^{ø} + \mu_{h}) + p\lambda_{h}\mu_{h}K_{2} + q\lambda_{h}\mu_{h}\xi\rbrack}$$Substitute [(6)](#eq0070){ref-type="disp-formula"} into [(5)](#eq0065){ref-type="disp-formula"}, we have the following equation in $\lambda_{h}^{ø}$ $$\lambda_{h}^{ø} = \frac{m_{1}m_{2}\mu_{h}\mu_{v}K_{3}(R_{0}^{2} - 1)}{N_{h}\mu_{h}\lbrack m_{2}K_{3}C_{hv}\xi\mu_{h} + m_{2}\mu_{v}K_{3}A + (r\mu_{v}K_{4} + q\mu_{v}\sigma_{v})(K_{3}C_{hv}\xi\mu_{h} + \eta\tau\xi\mu_{h}N_{h}\mu_{h})\rbrack}$$where $A = m_{1} + p\mu_{h}K_{2} + q\mu_{v}\sigma_{v}$. Clearly the model [(1)](#eq0005){ref-type="disp-formula"} has no endemic state if *R* ~0~ \< 1 and one unique endemic state when *R* ~0~ \> 1.  □

[Fig. 3](#fig0015){ref-type="fig"} shows the variation in *R* ~0~ with the relative fraction of newborn exposed individuals (p) and newborn infected individuals (q). We notice that no less than %5 of newborn exposed individuals (p) and no more than 25% of the fraction of newborn infected individuals to bring *R* ~0~ less than 1:Fig. 3Simulation of the model [(1)](#eq0005){ref-type="disp-formula"} showing the contour plot of *R*~0~ as a function of fraction of newborn exposed individuals (p) and newborn infected individuals (q).Fig. 3

[Fig. 4](#fig0020){ref-type="fig"} shows the effect of hospitalization rate *τ* of infected individuals on the basic reproductive number *R* ~0~. From this figure, we can see that effective isolation will help to reduce the basic reproductive number. About 25% of infected individuals should be effectively isolated to bring the basic reproductive number to less than 1. This plot shows that the effective isolation is helpful in controlling the epidemic of Zika virus.Fig. 4The effect of hospitalization rate *τ* of infected individuals versus basic reproductive number *R*~0~ for the model [(1)](#eq0005){ref-type="disp-formula"}.Fig. 4

### 3.2.1. Uniform persistence {#sec0030}

Let $\mathcal{I} = (E_{h},I_{h},H_{h},E_{v},I_{v})$. Then ${(\mathcal{I})}^{\prime}(t) = A(x(t))\mathcal{I}(t)$, where$$A(x) = \begin{pmatrix}
{- K_{1} + p\mu_{h}} & {q\mu_{h}} & 0 & 0 & {\frac{C_{hv}}{N_{h}}S_{h}} \\
\xi & {- K_{2}} & 0 & 0 & 0 \\
0 & 0 & {- K_{3}} & 0 & 0 \\
0 & {\frac{C_{hv}}{N_{h}}S_{v}} & {\frac{\eta C_{hv}}{N_{h}}S_{v}} & {- K_{4} + r\mu_{v}} & {s\mu_{v}} \\
0 & 0 & 0 & \sigma_{v} & {- K_{5}} \\
\end{pmatrix},$$denote by *s*(*A*) the spectral bound of matrix *A*. Let $\left. \rho:\mathbb{R}_{+}^{8}\rightarrow\mathbb{R}_{+} \right.$,$$\rho(x) = \min_{i = 1}^{4}\mathcal{I}_{i}.$$ Theorem 3.4*If R* ~0~ \> 1 *then the disease is strongly uniformly ρ-persistent:* ∃*ε* \> 0 *such that* $$\underset{t\rightarrow\infty}{\lim\inf}\rho(x(t)) > \varepsilon,$$ *whenever ρ*(*x*(0)) \> 0*. Where* $x(t) = (S_{h}(t),E_{h}(t),I_{h}(t),H_{h}(t),R_{h}(t),S_{v}(t),E_{v}(t),I_{v}(t)$ *be a solution of model* [(1)](#eq0005){ref-type="disp-formula"} *. In this case there exists an endemic steady state.* ProofLet $X = \{ x \in \mathbb{R}_{+}^{8} \mid \rho(x(t)) = 0\,\forall\, t \geq 0\}$. Then $X = \{ x \in \mathbb{R}_{+}^{8} \mid E_{h} = I_{h} = H_{h} = R_{h} = E_{v} = I_{v} = 0\}$ (that is, *X* is the disease-free subspace). Note that *X*, as well as $\mathbb{R}_{+}^{7}\backslash X$, are positively invariant. Also, all solutions originating in *X* converge to *N* ~0~ as *t* → ∞. *N* ~0~ is asymptotically stable in *X*. Hence *N* ~0~ is isolated in *X*. Corollary 4.7 in [@bib0150] (where *M* = *B* ∩ *X*, Ω(*M*) = {*N* ~0~}, *T* = 1, *P*(1, *N* ~0~) is *e* ^*A*(*N*~0~)^), together with Proposition 4.1 and Lemma 3.1 in [@bib0150], imply that {*N* ~0~} is also uniformly weakly repelling. Then, from Theorem 8.17 in [@bib0155] we have that the semiflow generated by (2.4) is uniformly weakly *ρ*-persistent. From the positive invariance of $\mathcal{B}$, we have that (2.4) is point dissipative. Then, according to Theorem 2.28 in [@bib0155], there exists a compact attractor of points for [(1)](#eq0005){ref-type="disp-formula"}. This, together with uniformly weakly *ρ*-persistent imply [(10)](#eq0090){ref-type="disp-formula"} (see [@bib0155], Theorem 5.2). In this case there exists an endemic steady state ([@bib0155]).  □

3.3. Stability of endemic state {#sec0035}
-------------------------------

The local stability of the endemic steady state $\mathcal{E}_{1}$ of the model [(1)](#eq0005){ref-type="disp-formula"} is given in the lemma below.Theorem 3.5*If R* ~0~ \> 1*, then the endemic state of the model* [(1)](#eq0005){ref-type="disp-formula"} *is locally asymptotically stable in for model* [(1)](#eq0005){ref-type="disp-formula"} *.*

for the proof of this above local stability theorem see [@bib0100].

For the global stability of the endemic steady state $\mathcal{E}_{1}$, we consider the [(1)](#eq0005){ref-type="disp-formula"} with no hospitalization and a small incubation period so that we can assume that susceptible individuals after infection move to infected class.

In this case, it is easily seen that both for the host population and for the vector population the corresponding total population sizes are asymptotically constant. We assumed that in our model the total population is constant. Previous results ([@bib0165]) imply that the dynamics of systems [(1)](#eq0005){ref-type="disp-formula"} is qualitatively equivalent to the dynamics of system given by:$$\begin{aligned}
\frac{{dS}_{H}}{dt} & {= \Pi_{H} - q\Pi_{H}I_{H} - \lambda_{H}S_{H} - \mu_{H}S_{H}} \\
\frac{{dI}_{H}}{dt} & {= \lambda_{H}S_{H} + q\Pi I_{H} - (\theta + \mu_{H})I_{H}} \\
\frac{{dI}_{V}}{dt} & {= \lambda_{V}(\frac{\Pi_{V}}{\mu_{V}} - I_{V}) - \mu_{V}I_{V}} \\
\end{aligned}$$

We study the following feasible region of the new system [(11)](#eq0095){ref-type="disp-formula"}:$$\begin{aligned}
{\mathcal{D} = \left\{ {(S_{H},I_{H},I_{V}) \in \mathbb{R}_{+}^{3}:S_{H} + I_{H} \leq \frac{\Pi_{H}}{\mu_{H}};} \right)} & \\
\left( {I_{V} \leq \frac{\Pi_{V}}{\mu_{V}}.} \right\} & \\
\end{aligned}$$

Denote the interior of $\mathcal{D}$ by $\mathcal{D}^{o}$.Theorem 3.6*If R* ~0~ \> 1*, then the endemic state of* [(11)](#eq0095){ref-type="disp-formula"} *is globally asymptotically stable in* $\mathcal{D}^{o}.$ ProofWe will use geometric approach to global-stability method given in [@bib0120]. Let *x* = (*S*, *I* ~*H*~, *I* ~*V*~) and *f*(*x*) denote the vector field of [(11)](#eq0095){ref-type="disp-formula"}. The Jacobian matrix $$J = \begin{bmatrix}
{C_{H}I_{V} - \mu_{H}} & {- q\Pi} & {- C_{H}S_{H}} \\
{C_{H}I_{V}} & {- \theta - \mu_{H}} & {C_{H}S_{H}} \\
0 & {C_{V}(\frac{\Pi_{V}}{\mu_{V}} - I_{V})} & {- \mu_{H} - C_{V}I_{H}} \\
\end{bmatrix}$$and its second additive compound matrix *J* ^\[2\]^ is (see [@bib0120]):$$J^{\lbrack 2\rbrack} = \begin{bmatrix}
{C_{H}I_{V} - 2\mu_{H} - \theta} & {C_{H}S_{H}} & {C_{H}S_{H}} \\
{C_{V}(\frac{\Pi_{V}}{\mu_{V}} - I_{V})} & {- C_{H}I_{V} - C_{V}I_{H} - \mu_{H} - \mu_{V}} & {- q\Pi_{H}} \\
0 & {C_{H}I_{V}} & {- C_{V}I_{H} - \mu_{H} - \mu_{V} - \theta} \\
\end{bmatrix}.$$Here $C_{H} = C_{V} = C_{HV}\frac{\mu_{H}}{\Pi_{H}}.$ Take the function *P*(*x*) as:$$P(x) = \begin{bmatrix}
1 & 0 & 0 \\
0 & {(1 - a_{2})\frac{I_{H}}{I_{V}}} & 0 \\
0 & 0 & \frac{I_{H}}{I_{V}} \\
 & & \\
\end{bmatrix}$$where$$a_{2} = \left\{ \begin{array}{ll}
0 & {{if}\text{ \,\,}\theta \geq \Pi_{H}} \\
{1 - \frac{\theta}{q\Pi_{H}}} & {{if}\text{ \,\,}\theta < \Pi_{H}.} \\
\end{array} \right)$$ $$P(x) = \begin{bmatrix}
B_{11} & B_{12} \\
B_{21} & B_{22} \\
\end{bmatrix}$$where *B* ~11~ =− *C* ~*H*~ *I* ~*V*~ − 2*μ* ~*H*~ − *θ* + *qΠ* ~*H*~, $B_{12} = (C_{H}\frac{S_{H}I_{V}}{I_{H}},)C_{H}\frac{S_{H}I_{V}}{I_{H}}),$ $B_{21} = {(C_{V}\frac{I_{H}}{I_{V}}(\frac{\Pi_{V}}{\mu_{V}} - I_{H}),0)}^{t}$ and$$B_{22} = \begin{bmatrix}
{\frac{I_{H}^{\prime}}{I_{H}} - \frac{I_{V}^{\prime}}{I_{V}} - C_{H}I_{V} - C_{V}I_{H} - \mu_{H} - \mu_{V} + q\Pi_{H}} & {- (1 - a_{2})q\Pi_{H}} \\
{C_{H}I_{V}} & {\frac{I_{H}^{\prime}}{I} - \frac{I_{V}^{\prime}}{I_{V}} - C_{V}I_{H} - \mu_{H} - \mu_{V} - \theta} \\
\end{bmatrix}$$ $$\mu(B) \leq \sup\{ g_{1},g_{2}\}$$where$$g_{1} = \mu(B_{11}) + |B_{12}|,\quad g_{2} = |B_{21}| + \mu(B_{22}).$$ $$\begin{aligned}
{\mu(B_{22})} & {= \frac{I_{H}^{\prime}}{I_{H}} - \frac{I_{V}^{\prime}}{I_{V}} - C_{V}I_{H} - \mu_{H} - \mu_{V} + \max\{ 0,q\Pi_{H} - \theta\}} \\
 & {\leq \frac{I_{H}^{\prime}}{I_{H}} - \frac{I_{V}^{\prime}}{I_{V}} - C_{V}I_{H} - \mu_{H} - \mu_{V}.} \\
\end{aligned}$$Therefore,$$q_{1} = C_{H}I_{V} - \theta - 2\mu_{H} + C_{H}\frac{S_{H}I_{V}}{I_{H}}$$ $$g_{2} = C_{V}\frac{I_{H}}{I_{V}}\left( {\frac{\Pi_{V}}{\mu_{V}} - I_{V}} \right) - C_{V}I_{H} - \mu_{H} - \mu_{V} + \frac{I_{H}^{\prime}}{I_{H}} - \frac{I_{V}^{\prime}}{I_{V}}.$$Now from the system [(11)](#eq0095){ref-type="disp-formula"}, we can write second and third equation,$$\begin{aligned}
{C_{H}\frac{S_{H}I_{V}}{I_{H}}} & {= (\theta + \mu_{H}) + \frac{I_{H}^{\prime}}{I_{H}}} \\
{C_{V}\Pi_{V}\frac{I_{H}}{\mu_{V}I_{V}}} & {= \mu_{V} + I_{H} + \frac{I_{V}^{\prime}}{I_{V}}.} \\
\end{aligned}$$ $$q_{1} \leq \frac{I_{H}^{\prime}}{I_{H}} - \mu_{H}$$

4. Sensitivity analysis {#sec0040}
=======================

The variation in the values of the parameters of our model [(1)](#eq0005){ref-type="disp-formula"} is a source of uncertainty and sensitivity. In this section, we carry out a parameter base global uncertainty and sensitivity analyses on *R* ~0~. There are a lot of reasons for the sensitivity of the parameters, for example, inadequate data, lack of information about the vertical transmission. We use the Latin-hypercube sampling based method to quantify the uncertainty and the sensitivity of *R* ~0~ as a function of the model parameters.

We use the Latin-hypercube sampling based method to quantify the uncertainty and the sensitivity of *R* ~0~ as a function of 13 model parameters, namely $\mu_{h},\mu_{v},\theta_{I},\theta_{H},\xi,\sigma_{v},p,q,r,s,C_{hv},\tau,\eta.$ The Partial Rank Correlation Coefficient (PRCC) measures the impact of the parameters on the output variable using the rank transformation of the data to reduce the effects of nonlinearity. The uncertainty analysis ([Fig. 5](#fig0025){ref-type="fig"}, [Fig. 6](#fig0030){ref-type="fig"} ) yields an estimated value of *R* ~0~ = 1.54 with 95% CI (1.3491, 1.7669) for the Zika fever.Fig. 5Uncertainty analysis.Fig. 5Fig. 6Uncertainty analysis.Fig. 6

The sensitivity analysis suggests that *R* ~0~ is highly sensitive to the parameters $C_{hv},\theta_{I},\theta_{H},\mu_{v},\tau.$ The accuracy and precision in the values of these parameters is vital for the accurate predictions of the model.

The estimated parameters are presented in [Table 3](#tbl0015){ref-type="table"} .Table 3Mean values of the model parameters with their assigned distributions. *N* and *G* represents the normal and gamma distribution respectively.Table 3ParameterMean, Std.DevDistribution*μ*~*h*~(0.000042, 9.91365*e*08)*N*$\mu_{v}$(0.100011, 0.00100085)*NC*~*hv*~(0.200012, 0.0100131)*Gξ*(0.329517, 0.049668)*Np*(0.049971, 0.00997859)*Nq*(0.050071, 0.0100389)*Nr*(0.049987, 0.00100176)*Ns*(0.049992, 0.000993712)*Nθ*~*I*~(0.500184, 0.0497701)*Nθ*~*H*~(0.010047, 0.0497031)*Nτ*(0.499627, 0.0498795)*Nη*(0.249814, 0.0501395)*N*$\sigma_{v}$(0.999899, 0.0100992)*N*

5. Optimal control for the isolation model [(1)](#eq0005){ref-type="disp-formula"} {#sec0045}
==================================================================================

One of the goals of this study is to come up with a time-dependent hospitalization/isolation strategy that would minimize the infected population while keeping the costs to a minimum at the same time. Optimal control is a very useful mathematical technique that can help us to address these questions. Here our goal is to put down infection from the population by increasing the recovered class and to minimize the required resources to control Zika fever infection using isolation or hospitalization.

The optimal control algorithm we use is based on Pontrygain\'s Maximum Principle which appends the original model to an adjoint system of differential equations with terminal conditions. The optimal objective system, which characterizes the optimal controls, consists of differential equations of the original model (state system) along with the adjoint differential equations (the adjoint system). The number of equations in the adjoint system is same as that of in the state system. The detailed mechanism of forming the necessary conditions for the adjoint and optimal controls are discussed in [@bib0060] and [@bib0140].

An important decision while formulating an optimal control problem is deciding how and where to introduce the control in the system of differential equations. The form of the optimal control primarily depends on the system being analyzed and the objective function to be optimized. In this paper, we will propose various strategies to eradicate Zika fever using optimal control techniques.

5.1. Hospitalization control {#sec0050}
----------------------------

The first step is to find an optimal hospitalization schedule that minimizes the number of infectious individuals and the overall cost of hospitalization during a fixed time. We define the control set as **U**= {*τ*(*t*) : 0 ≤ *τ*(*t*) ≤ *ζ*, 0 ≤ *t* ≤ *T*, 0 \< *ζ* ≤ 1, *τ*(*t*) is Lebesgue measurable}. Here *ζ* is a positive number and is defined as the maximum value attained during optimal control procedure. Our aim is to minimize the associated cost function which is given as:$$J\lbrack\tau\rbrack = {\int_{0}^{T}{\left\lbrack {A_{I}I_{h} + A_{N}N_{v} + \frac{1}{2}W\tau^{2}(t)} \right\rbrack{dt}}}$$Here *A* ~*I*~ and *A* ~*N*~ are positive constants used to balance in the size of *I*(*t*) and $N_{v}(t)$. Further, we used a nonlinear cost function in order to accommodate the impact of variety of factors associated with hospitalization, documented widely in literature, see for instance [@bib0115]. *W* is weight associated with quadratic cost due to hospitalization. Moreover a linear function has been chosen for cost incurred by infected individuals and the mosquitoes population. Our objective is to find an optimal control for hospitalization rate *τ* ^\*^(*t*) such that $J\lbrack\tau^{*}\rbrack = \min\limits_{\tau\epsilon U}\text{ \,\,}J\lbrack\tau\rbrack$. The Lagrangian of the optimization problem is given by $L = A_{I}I_{h} + \frac{1}{2}W\tau^{2}(t)$. The associated "Hamiltonian" is given by$$H^{*} = A_{I}I_{h} + \frac{1}{2}W\tau^{2}(t) + \sum\limits_{i = 1}^{8}\phi_{i}k_{i}$$where *k* ~*i*~ represents the right hand side of the *i*th equation in our original model. *W* depends on the relative importance of the control measures in mitigating the spread of the disease as well as the cost incurred (such as material resources and human effort) during the implementation of control measure per unit time. Pontrayagin\'s Maximum Principal converts model [(1)](#eq0005){ref-type="disp-formula"} and objective function [(16)](#eq0175){ref-type="disp-formula"} into minimizing the Hamiltonian [(17)](#eq0180){ref-type="disp-formula"} with respect to *τ*. Now we prove the following theorem to elicit the effect of optimal control of hospitalization.Theorem 5.1*There exists a unique optimal control τ* ^\*^(*t*) *which minimizes J over* **U** *. Also, there exists an adjoint system of ϕ* ~*i*~ *\'s such that the optimal treatment control is characterized as* $$\tau^{*}(t) = \min\left\lbrack {\zeta,\max\left( {0,\frac{I_{h}(\phi_{3} - \phi_{4})}{W}} \right)} \right\rbrack$$ *for some positive number ζ. The adjoint system is given as* $$\begin{aligned}
\frac{d\phi_{1}}{dt} & {= \left( {\frac{C_{hv}I_{v}}{N_{h}} + \mu_{h}} \right)\phi_{1} - \frac{C_{hv}I_{v}}{N_{h}}\phi_{2}} \\
\frac{d\phi_{2}}{dt} & {= p\mu_{h}\phi_{1} - p\mu_{h}\phi_{2} + (\xi + \mu_{h})\phi_{2} - \xi\phi_{3}} \\
\frac{d\phi_{3}}{dt} & {= - A_{I} + q\mu_{h}\phi_{1} - q\mu_{h}\phi_{2} + (\theta_{I} + \tau + \delta_{I} + \mu_{h})\phi_{3} - \tau\phi_{4} - \theta_{I}\phi_{5} + \frac{C_{hv}S_{v}}{N_{h}}\phi_{6} - \frac{C_{hv}S_{v}}{N_{h}}\phi_{7}} \\
\frac{d\phi_{4}}{dt} & {= (\theta_{H} + \delta_{H} + \mu_{h})\phi_{4} - \theta_{h}\phi_{5} + \frac{\eta C_{hv}S_{v}}{N_{h}}\phi_{6} - \frac{\eta C_{hv}S_{v}}{N_{h}}\phi_{7}} \\
\frac{d\phi_{5}}{dt} & {= \mu_{h}\phi_{5}} \\
\end{aligned}$$ *The above adjoint system also satisfies the transversality condition,* {*ϕ* ~*i*~(*T*) = 0 : *i* = 1, *b*, ..., 8}*.* ProofWe can easily verify that the integrand of *J* is convex with respect to *τ*(*t*). Also, the solutions of our model are bounded above. In addition, it is verifiable that the model has the Lipschitz property with respect to the state variables. Using the properties mentioned above along with corollary 4.1 of [@bib0060], the existence of an optimal control is established.Now using the Pontryagin\'s Maximum Principle, we obtain $$\begin{aligned}
\frac{d\phi_{1}}{dt} & {= - \frac{\partial H^{*}}{\partial S_{h}},\quad\phi_{1}(T) = 0} \\
\frac{d\phi_{2}}{dt} & {= - \frac{\partial H^{*}}{\partial E_{h}},\quad\phi_{2}(T) = 0} \\
 & {\vdots \quad \vdots \quad \vdots} \\
\frac{d\phi_{8}}{dt} & {= - \frac{\partial H^{*}}{\partial I_{v}},\quad\phi_{8}(T) = 0} \\
 & \\
\end{aligned}$$evaluated at the optimal control which results in the above stated adjoint system. The optimality condition is $\frac{\partial H}{\partial\tau} = 0$. Therefore on the set {*T* : 0 \< *τ* ^\*^(*T*) \< *ζ*} we obtain$$\tau^{*}(t) = \frac{I_{h}(\phi_{3} - \phi_{4})}{W}$$

Now, we discuss the numerical solutions of the optimality system and the corresponding optimal control obtained using *ζ* = 0.5. The optimal strategy is obtained by solving the optimal system consisting of both the state system as well as the adjoint system. Since there are initial conditions present for the state equations, we start solving them with a guess for *τ* using the fourth-order forward Runge-Kutta method. The adjoint equations are then solved using the fourth-order backward Runge-Kutta method because of the presence of final conditions. Then, the controls are updated by using a convex combination of the previous control and the value from the characterization given above. This process is repeated until we obtain a desired accuracy of convergence ([Fig. 7](#fig0035){ref-type="fig"} ).Fig. 7Sensitivity analysis.Fig. 7

[Fig. 8](#fig0040){ref-type="fig"} represents the optimal isolation(hospitalization) strategy to be employed to minimize the cost and the infected population. Considering the practical constraints, an upper bound of 0.5 was chosen for the optimal hospitalization control. The figure shows that initially, the optimal level remains at the upper bound of 0.5 after which it declines steadily to 0. This implies that in the early phase of the endemic breakout, keeping the control at the upper bound would help in decreasing the number of infected individuals.Fig. 8Optimal hospitalization control.Fig. 8

[Fig. 9](#fig0045){ref-type="fig"} captures the dynamics of the infected population (*I* ~*H*~) by virtue of a comparison between the infected host population under optimal control and constant control. It can be seen that the decrease in the number of infected individuals is greater with optimal control as compared to that with constant control. Furthermore, in contrast with a constant control, the infected population remains lower when an optimal control is applied.Fig. 9Comparison of total infected host population under optimal and constant control.Fig. 9

[Fig. 10](#fig0050){ref-type="fig"} shows a comparison between the costs associated with optimal and different constant control strategies. It is clear that the cost associated with different control strategies is higher as compared to that of optimal control. It is important to note that high constant isolation rate (*τ* = 0.4) incurs almost the same cost as the of optimal control. However, practically it is highly unlikely to implement these high constant controls primarily due to the lack of required resources and facilities. [Fig. 11](#fig0055){ref-type="fig"} captures the effect of the change in effective contact rate over the optimal control strategy. It is clear from the simulation that an increase in the contact rate may or may not lead to higher rates of hospitalization.Fig. 10Comparison of associated costs under optimal and constant control.Fig. 10Fig. 11Optimal hospitalization control for different values of effective contact rate *C*~*hv*~.Fig. 11

6. Discussion {#sec0055}
=============

In this paper, we have presented a Zika fever epidemic model comprising of eight compartments consists of vector and human population. The dynamics of Zika fever epidemic model have been considered. Furthermore, using optimal control theory, we proposed control strategies to eliminate the infection from the population.

A vertical and horizontal transmission model for Zika fever is constructed in the form of a system of ordinary differential equations. This model features the study of Zika fever by considering vertical transmission in both humans as well as vectors. The basic reproductive number *R* ~0~ is formulated by using a next-generation matrix. This reproductive number is simplified in order to better understand the effect of vertical transmission parameters. It is shown that the disease-free steady state is globally asymptotically stable when the basic reproductive number (*R* ~0~) is less than 1. The model has a unique endemic equilibrium when the reproduction number *R* ~0~ exceeds unity. This equilibrium is shown to be globally asymptotically stable when the reproduction number *R* ~0~ exceeds unity under the reduced model. It is locally asymptotically stable when we consider a full model.

We performed a parameter based global uncertainty and sensitivity analysis on *R* ~0~. The uncertainty analysis yields an estimated value of the basic reproductive number *R* ~0~ = 1.54 with 95% confidence interval (1.3491, 1.7669). This estimated value of *R* ~0~ is close to the calculated value of basic reproductive using real data ([@bib0175]). Our previous model had an estimated basic reproductive number *R* ~0~ = 1.31 with 95% confidence interval (1.23, 1.39) given in [@bib0100]. Our sensitivity analysis on the Zika model parameters showed that the most influential parameters are the effective contact rates, the recovery rate of the infected individuals and the birth rate of mosquitoes.

We proposed an optimal controlling strategy to eliminate Zika fever from the population. We observed that optimal control strategy is most effective in terms of eliminating infection as it minimizes our cost and resources at the same time. Moreover, the control measures themselves may take time to implement, once the outbreak has been realized. Despite these points, our analysis can help public health authorities to determine quasi-optimal strategies they might want to adopt, especially as our work highlights the relative effectiveness of different control strategies.
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